CURIST ALLERGY RELIEF- levocetirizine dihydrochloride 5 mg tablet 
Little Pharma, Inc.

----------

Curist Allergy Relief Tablet (levocetirizine 5 mg)

Drug Facts

Active ingredient (in each tablet)

Levocetirizine dihydrochloride USP 5 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

Warnings

Do not use

  • if you have kidney disease
  • if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine

Ask a doctor before use if you have ever had trouble urinating or emptying your bladder.

When using this product

  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

  • you have trouble urinating or emptying your bladder
  • an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

  • if breast-feeding: not recommended
  • if pregnant: ask a health professional before use

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

adults 65 years and olderask a doctor
adults and children 12-64 years
  • take 1 tablet (5 mg) once daily in the evening
  • do not take more than 1 tablet (5 mg) in 24 hours
  • ½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
children 6-11 years
  • take ½ tablet (2.5 mg) once daily in the evening
  • do not take more than ½ tablet (2.5 mg) in 24 hours
children under 6 yearsdo not use
consumers with kidney diseasedo not use

Other information

  • ​store between 20° and 25°C (68° and 77°F)
  • safety sealed: do not use if carton was opened or torn, or if printed inner seal on bottle is torn or missing

Inactive ingredients

colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, titanium dioxide.

Questions?

Call 1-844-243-1241 or email hi@curistrelief.com

Read directions and warnings before use. Keep carton as it contains important information.

Distributed by:

Little Pharma, Inc. New York, NY 10023

Made in India

curistrelief.com

curist

Allergy Relief

Levocetirizine Dihydrochloride Tablets, USP 5 mg

Antihistamine

24 Hour Relief of Runny Nose; Sneezing; Itchy, Watery Eyes; Itchy Nose or Throat

Clinically Proven Relief in 60 Minutes

90 Tablets

actual size

allergy relief artwork

CURIST ALLERGY RELIEF 
levocetirizine dihydrochloride 5 mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72559-021
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LEVOCETIRIZINE DIHYDROCHLORIDE (UNII: SOD6A38AGA) (LEVOCETIRIZINE - UNII:6U5EA9RT2O) LEVOCETIRIZINE DIHYDROCHLORIDE5 mg
Inactive Ingredients
Ingredient NameStrength
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
HYPROMELLOSE 2910 (3 MPA.S) (UNII: 0VUT3PMY82)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorwhiteScore2 pieces
ShapeOVALSize8mm
FlavorImprint Code LL;H
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72559-021-051 in 1 CARTON01/24/2023
190 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA21351301/24/2023
Labeler - Little Pharma, Inc. (074328189)
Establishment
NameAddressID/FEIBusiness Operations
Nutra-Med Packaging Inc.022004902pack(72559-021)

Revised: 1/2023
 
Little Pharma, Inc.